Lopinavirritonavir Lpvr | List of Frontiers open access articles

Original Research

Published on 12 Dec 2019

Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China

in Drugs Outcomes Research and Policies

Bin Su
Yin Wang
Ruifeng Zhou
Taiyi Jiang
Hongwei Zhang
Zaicun Li
An Liu
Ying Shao
Wei Hua
Tong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01472

6,849 views
39 citations

Systematic Review

Published on 13 Jun 2025

The prevalence of dyslipidemia and its correlation with anti-retroviral therapy among people living with HIV in China: a systematic review and meta-analysis

in General Cardiovascular Medicine

Zhai Wenjing
Ouyang Fei
Zhan Shenao
Huang Yu
Fu Gengfeng
Yang Haitao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1498165

2,660 views

Original Research

Published on 22 Apr 2021

No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison

in Drugs Outcomes Research and Policies

Roberta Gagliardini
Alessandro Cozzi-Lepri
Andrea Mariano
Fabrizio Taglietti
Alessandra Vergori
Amina Abdeddaim
Francesco Di Gennaro
Valentina Mazzotta
Alessandra Amendola
Giampiero D’Offizi

Frontiers in Pharmacology

doi 10.3389/fphar.2021.621676

4,170 views
8 citations

Original Research

Published on 09 Jun 2021

Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study

in Infectious Diseases – Surveillance, Prevention and Treatment

Augusto Di Castelnuovo
Simona Costanzo
Andrea Antinori
Nausicaa Berselli
Lorenzo Blandi
Marialaura Bonaccio
Raffaele Bruno
Roberto Cauda
Alessandro Gialluisi
Giovanni Guaraldi

Frontiers in Medicine

doi 10.3389/fmed.2021.639970

9,427 views
27 citations

Systematic Review

Published on 27 Feb 2024

Comparative risk of adverse perinatal outcomes associated with classes of antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis

in Obstetrics and Gynecology

Katharina Beck
Imogen Cowdell
Clara Portwood
Harriet Sexton
Mary Kumarendran
Zoe Brandon
Shona Kirtley
Joris Hemelaar

Frontiers in Medicine

doi 10.3389/fmed.2024.1323813

4,095 views
17 citations

Clinical Trial

Published on 14 Jul 2020

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study

in Drugs Outcomes Research and Policies

Yin-Qiu Huang
Sheng-Quan Tang
Xiao-Lei Xu
Yan-Ming Zeng
Xiao-Qing He
Yao Li
Vijay Harypursat
Yan-Qiu Lu
Yan Wan
Lu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01071

10,767 views
48 citations

Articles

Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China

The prevalence of dyslipidemia and its correlation with anti-retroviral therapy among people living with HIV in China: a systematic review and meta-analysis

No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison

Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study

Comparative risk of adverse perinatal outcomes associated with classes of antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis